Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Multidrug Resistant Bacteria, and the Implication of a Positive Screening Result Compared to a Negative on Subsequent Infection and Mortality.

NCT06370299 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06370299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06370299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Multidrug Resistant Bacteria, and the Implication of a Positive Screening Result Compared to a Negative on Subsequent Infection and Mortality.
Lead sponsor
Region Skane
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2024
Completion date
June 30, 2025
Enrollment
10,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multi-antibiotic resistance